Login

Elis, Rings European Trading Day in Paris | Xavier Martiré - Chairman of the Management Board and Chief Executive Officer of Elis SA 00:10:00

Share On Facebook Share On Twitter

Xavier Martire is Chairman-Mgmt Board/CEO at Elis SA.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Millicom CEO Mauricio Ramos credits Tigo employees for fostering a workplace committed to diversity, equity, and inclusion.
00:10:00
Real Estate and the Pandemic: A Conversation with Fábio Tadeu Araújo and Fabricio Mitre | Fabrício Mitre, CEO , Mitre Realty Empreendimentos e Participações SA.
00:10:00
Montana Energy 2016: Keynote by Colin Marshall | Colin Marshall - CEO & President of Cloud Peak Energy.
00:10:00
Unbundling The Fintech Opportunity|Marc Andrusko,Partner,Andreessen Horowitz
00:10:00
Mock Interview at Jane Street: A Guide to Their Process and Tips
00:10:00
Thomas Olin Highlights Kancera’s Latest Advances and Strategic Focus | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
led investment rounds for legal AI platform Harvey and online mental health platform Grow Therapy|Pat Grady,partner,Sequoia
00:10:00
Ole Kristian Jødahl, CEO of Alimak Group (ALIG), features in VD-interviews on Investor Relations.|OLE KRISTIAN JØDAHL is PRESIDENT AND CEO Alimak Group
00:10:00
Senior Resources: Advancing Twin Hills Gold Project in Namibia with Prominent Shareholders
00:10:00
Market Challenges and Investment Strategies with Hilltop’s CEO Derek Kelly | Derek Kelly, CEO, Hilltop Financial Planning.
00:10:00
Challenges and Growth Factors in Renewable Energy Market Revealed | Dr. Christoph Husmann, CEO, Encavis AG.
00:10:00
Copper Market Outlook: Post-COVID-19 Recovery and Future Projections

© 2017 - Neuhu+